Klaus Überla
Impact in
- Virology top 0.2%
- HIV Research and Treatment
- Infectious Diseases top 0.5%
- Viral gastroenteritis research and epidemiology
- SARS-CoV-2 and COVID-19 Research
- HIV/AIDS drug development and treatment
Papers in
- Virology 68
- HIV Research and Treatment 67
-
- SARS-CoV-2 and COVID-19 Research 25
- HIV/AIDS drug development and treatment 17
- Co-authors
- Ibrahim Ahmed Hamza (5 shared papers)Michael Wilhelm (5 shared papers)Lars Jurzik (5 shared papers)Vladimir Temchura (40 shared papers)Thomas Grünwald (22 shared papers)Tibor Diamantstein (8 shared papers)Thomas Blankenstein (7 shared papers)Seraphin Kuate (15 shared papers)
- Journals
- Journal of Virology (26 papers)Vaccine (9 papers)PLoS ONE (7 papers)Retrovirology (7 papers)Viruses (6 papers)
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Klaus Überla
195 papers receiving 6.2k citations
Peers
Comparison fields: 5 of 146
- Virology 1.5k
- Infectious Diseases 2.1k
- Immunology 1.9k
- Epidemiology 1.2k
- Animal Science and Zoology 378
Countries citing papers authored by Klaus Überla
This map shows the geographic impact of Klaus Überla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Überla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Überla more than expected).
Fields of papers citing papers by Klaus Überla
This network shows the impact of papers produced by Klaus Überla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Überla. The network helps show where Klaus Überla may publish in the future.
Co-authors
The 25 scholars most cited alongside Klaus Überla, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 199 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1991 | 244 | |
| 2 | 2005 | 210 | |
| 3 | 2010 | 189 | |
| 4 | 2009 | 177 | |
| 5 | 2004 | 157 | |
| 6 | 2009 | 151 | |
| 7 | 1998 | 146 | |
| 8 | 2008 | 140 | |
| 9 | 2007 | 133 | |
| 10 | 2000 | 125 | |
| 11 | 1992 | 121 | |
| 12 | 2011 | 119 | |
| 13 | 2006 | 110 | |
| 14 | 1995 | 104 | |
| 15 | 2000 | 101 | |
| 16 | 2005 | 88 | |
| 17 | Vaccinations with tumor cells genetically engineered to produce different cytokines: effectivity not superior to a classical adjuvant. | 1993 | 85 |
| 18 | 1991 | 75 | |
| 19 | 2010 | 73 | |
| 20 | 1999 | 73 |
About Klaus Überla
Klaus Überla is a scholar working on Virology, Infectious Diseases, Immunology, Molecular Biology and Epidemiology, having authored 199 papers that have together received 6.3k indexed citations. Recurring topics across this work include HIV Research and Treatment (67 papers), Immunotherapy and Immune Responses (37 papers), Virus-based gene therapy research (27 papers), Immune Cell Function and Interaction (27 papers), SARS-CoV-2 and COVID-19 Research (25 papers), HIV/AIDS drug development and treatment (17 papers), T-cell and B-cell Immunology (15 papers) and RNA Interference and Gene Delivery (14 papers). The work is most often cited by research in Virology (1.5k citations), Infectious Diseases (2.1k citations), Immunology (1.9k citations), Epidemiology (1.2k citations) and Animal Science and Zoology (378 citations). Klaus Überla has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Ibrahim Ahmed Hamza, Michael Wilhelm, Lars Jurzik, Vladimir Temchura, Thomas Grünwald, Tibor Diamantstein, Thomas Blankenstein, Seraphin Kuate, Matthias Tenbusch and Alexander Stang. Their work appears in journals such as Journal of Virology, Vaccine, PLoS ONE, Retrovirology and Viruses.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.